A Comparative Investigation of Efficacy and Complications in Light and Deep Chemical Peels

Active, not recruiting

• Conditions: Peeling Skin Syndrome

• Registration Number: NCT06749561
• Lead Sponsor: Superior University

Brief Summary

Chemical peeling involves applying substances to the skin to induce controlled damage, which promotes the regeneration of fresh skin cells and enhances the skin's appearance.

Detailed Description

This study will be a cross-sectional analysis with a sample size of 112 patients.

Study Timeline

• Study Start: 2024-02-01
• Primary Completion: 2024-08-01
• Status Verified: 2024-12
• Study First Submitted: 2024-12-19
• Study First Submitted QC: 2024-12-19
• Last Update Submitted: 2024-12-19
• Study First Posted: 2024-12-27
• Last Update Posted: 2024-12-27
• Study Completion: 2025-03-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: Female
• Target Recruitment: 112

Inclusion Criteria

• Healthy males and females aged 18-35 years.
• Willing to provide informed consent and follow the treatment protocol.

Exclusion Criteria

• Pregnant or breastfeeding women.
• Active skin conditions (e.g., acne, eczema).
• Use of medications that affect skin healing.
• Known allergies to chemical peel substances.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dermatological Assessment Score (DAS)	12 Months	The area-wise percentage involvement of the involved sites is calculated as: 1 = less than 10% area; 2 = 10-29%; 3 = 30-49%; 4 = 50-69%; 5 = 70-89%; and 6 = more than 90%. The maximum score of PASI is 72. PASI 75 is a 75% reduction of baseline PASI score.

Trial Locations

Locations (1)

Block E3 E-3 Gulberg III; 🇵🇰 Lahore, Punjab, Pakistan